|
|
 |
2009:
 |
Successful US FDA inspection of all 5 clinical trial sites and Ahmedabad Facility |
 |
Successful inspection of Ahmedabad and Mumbai facilities by OGYI - Hungarian Medical Regulatory Authority |
 |
Successful inspection of Poland Facilities by Austrian Regulatory Authority
|
|
 |
2008:
 |
ANVISA approval received for new Ahmedabad
facility |
 |
Approval by CAP (College of American
Pathologists, USA) for the new facility |
 |
Lambda built a world-class infrastructure spread
over 250,000 sq. ft. at Ahmedabad, India. All the services at
Ahmedabad headquarters have been operational from this new premises
“Lambda House” since the beginning of year 2008 with 264 beds |
 |
Entry into the pharmacovigilance segment by
acquisition of PV solutions Ltd, UK |
 |
Development of an ECG core lab and the capability
to undertake QT-QTc studies |
 |
Successful completion of an osteoarthritis phase
III study on 1886 subjects from 43 sites within 7 months for EMEA
submission |
 |
Lambda conducted many studies on unconventional
population subjects like postmenopausal females, surgically sterile
females, geriatrics, renal-impaired and hepatic impaired subjects |
 |
Lambda developed bioanalytical methods on many
new molecules like bisphosphonates (alendronate, ibandronate and
risedronate), Vitamin D, hormones, Ezetimibe etc.
|
|
 |
2007:
 |
First successful USFDA inspection at Mumbai |
 |
Acquisition of CBK-MPR in Poland to gain
operational presence in Europe |
 |
DCGI, India grants approval to the Ahmedabad facility
|
|
 |
2006:
 |
As a part of business
expansion, bed capacity increased by 60 beds to 120 beds at Ahmedabad |
 |
Screening facility at
Mehsana and Patan in Gujarat |
|

 |
2005:
 |
Our Clinical Lab, the fifth
in country to get accredited by College of American Pathologists |
 |
First successful USFDA
inspection |
 |
Initiated Scientific Data
Management System (SDMS) for Bioanalytical Laboratory
|
|
 |
2004:
 |
Our facility got satisfactorily inspected by
the regulatory bodies like ANVISA, WHO and AFSSAPS (France)
|
|
 |
2003:
 |
As a part of business
expansion, started phase II and III clinical trials. |
 |
Expanded our operations to
Mumbai
|
|
 |
2001:
 |
As an add-on to our
infrastructure, started our own Clinical Laboratory with most
sophisticated instruments
|
|
 |
1999:
 |
Started our operations at
Ahmedabad with a team of 6 members and an infrastructure of 24 beds,
1 LC/MS and 6 HPLCs |
|
|
|